Ionis Pharmaceuticals EBITDA 2010-2024 | IONS

Ionis Pharmaceuticals EBITDA for the quarter ending September 30, 2024 was $-0.151B, a 4.68% increase year-over-year.

  • Ionis Pharmaceuticals 2023 EBITDA was -0.354B, a 5.74% decline from 2022.
  • Ionis Pharmaceuticals 2022 EBITDA was -0.375B, a 3199.8% decline from 2021.
  • Ionis Pharmaceuticals 2021 EBITDA was 0.012B, a 108.64% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Ionis Pharmaceuticals EBITDA 2010-2024 | IONS

  • Ionis Pharmaceuticals 2023 EBITDA was -0.354B, a 5.74% decline from 2022.
  • Ionis Pharmaceuticals 2022 EBITDA was -0.375B, a 3199.8% decline from 2021.
  • Ionis Pharmaceuticals 2021 EBITDA was 0.012B, a 108.64% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.